CHRONIC MYELOPROLIFERATIVE NEOPLASMS: A COLLABORATIVE APPROACH

CHRONIC MYELOPROLIFERATIVE NEOPLASMS: A COLLABORATIVE APPROACH

Show other versions (1)

The classic chronic myeloproliferative neoplasms (MPN) include different entities that pose significant challenges for their optimal diagnosis, treatment and overall management. Polycythemia Vera and Essential Thrombocythemia are the most common among chronic myeloproliferative neoplasms (MPNs); maj...

Full description

Saved in:

Bibliographic Details
Main Authors:	Lisa Pieri, Paola Guglielmelli, Alessandro Maria Vannucchi
Format:	Article
Language:	English
Published:	PAGEPress Publications 2010-06-01
Series:	Mediterranean Journal of Hematology and Infectious Diseases
Subjects:	Myeloproliferative neoplasms
Online Access:	http://www.mjhid.org/index.php/mjhid/article/view/171
Tags:	Add Tag No Tags, Be the first to tag this record!

Similar Items

CHRONIC MYELOPROLIFERATIVE NEOPLASMS: A COLLABORATIVE APPROACH
by: Paola Guglielmelli, et al.
Published: (2010-05-01)

Real-world status of treatment for lymphoid neoplasms developed during the course of myeloproliferative neoplasms in Japan
by: Yoko Edahiro, et al.
Published: (2024-12-01)

MERGE: A Multinational, Multicenter Observational Registry for Myeloproliferative Neoplasms in Asia, including Middle East, Turkey, and Algeria
by: Mohamed A. Yassin, et al.
Published: (2020-07-01)

Enhanced Platelet Activity May Increase The Risk of Myocardial Infarction and Stroke in Patients with Chronic Myeloproliferative Neoplasms
by: Viola Maria Popov, et al.
Published: (2014-08-01)

Ph-NEGATIVE CHRONIC MYELOPROLIFERATIVE NEOPLASM (PRIMARY MYELOFIBROSIS) – AS ONE OF THE REASONS OF THE BUDD-CHIARI SYNDROME. CLINICAL CASE OF A YOUNG PATIENT.
by: Manana Alexandrovna Sokolova, et al.
Published: (2014-08-01)

The characteristics of CALR mutations in myeloproliferative neoplasms: a clinical experience from a tertiary care center in Qatar and a literature review
by: Mostafa Najim, et al.
Published: (2024-12-01)

THE JAK2V617F POINT MUTATION INCREASES THE OSTEOCLAST FORMING ABILITY OF MONOCYTES IN PATIENTS WITH CHRONIC MYELOPROLIFERATIVE NEOPLASMS AND MAKES THEIR OSTEOCLASTS MORE SUSCEPTIBLE TO JAK2 INHIBITION
by: Emmanouil Spanoudakis, et al.
Published: (2018-10-01)

Secondary Solid Cancers in Patients with Philadelphia Chromosome-Negative Myeloproliferative Neoplasms: A Multicenter Study
by: Fehmi Hindilerden, et al.
Published: (2024-12-01)

Leveraging big data and artificial intelligence for smarter trials in myeloproliferative neoplasms
by: Joshua W. Bliss, et al.
Published: (2024-12-01)

Regulation of STAT5 phosphorylation and interaction with SHP1 by lnc-AC004893, a long non-coding RNA overexpressed in myeloproliferative neoplasms
by: Junjun Yang, et al.
Published: (2024-12-01)

Megakaryocyte contribution to bone marrow fibrosis: many arrows in the quiver
by: Alessandro Malara, et al.
Published: (2018-11-01)

Prevalence and clinicopathological features of driver gene mutations profile in BCR:ABL1 negative classical myeloproliferative neoplasm—A single-center study from North India
by: Khaliqur Rahman, et al.
Published: (2024-12-01)

To the problem of thrombus-hemorrhagic complications in chronic myeloproliferative neoplasias. Complicated diagnosis. Clinical case conference
by: Nikolayenko-Kamyshova T.P.
Published: (2015-09-01)

Elevated Vitamin B12 Levels in Myeloproliferative Neoplasm (MPN) Patients: A Potential Diagnostic and Prognostic Marker
by: Fadul A, et al.
Published: (2024-12-01)

To the problem of thrombus-hemorrhagic complications in chronic myeloproliferative neoplasias. Complicated diagnosis. Clinical case conference.
by: T. P. Nikolayenko-Kamyshova
Published: (2015-09-01)

Insights into the role of JAK2-I724T variant in myeloproliferative neoplasms from a unique cohort of New Zealand patients
by: Christopher Puli'uvea, et al.
Published: (2024-12-01)

Ph-NEGATIVE CHRONIC MYELOPROLIFERATIVE DISORDER (IDIOPATHIC MYELOFIBROSIS) – AS ONE OF THE REASONS OF THE BUDD-CHIARI SYNDROME. CLINICAL CASE OF A YOUNG PATIENT
by: Maria Dmitrievna Sanatko
Published: (2014-08-01)

A rare clinical presentation of mastocytosis in an infant
by: Julia Hofmann, et al.
Published: (2024-11-01)

MPN in the guise of nutritional deficiency
by: Veda P
Published: (2014-08-01)

Washed microbiota transplantation stopped recurrent sepsis in a patient with myelofibrosis: a case report
by: Yingqi Yang, et al.
Published: (2024-12-01)

The survivin/XIAP suppressant YM155 impairs clonal growth and induces apoptosis in JAK2V617F cells
by: Jorge Antonio Elias Godoy Carlos, et al.
Published: (2024-12-01)

Ruxolitinib and pegylated interferon in Chronic Neutrophilic Leukemia due to a pathogenic CSF3R germline variant: a case report
by: Selene Grano, et al.
Published: (2024-12-01)

Immune‐dysregulation harnessing in myeloid neoplasms
by: Mohammad Jafar Sharifi, et al.
Published: (2024-09-01)

Coexistence of Chronic Lymphocytic Leukemia and Myeloproliferative Neoplasm
by: Patrycja Zielinska, et al.
Published: (2014-01-01)

Analysis of MicroRNA -155-5p Expression in Patients with Primary Myelofibrosis.
by: Sarah I. Khaleel, et al.
Published: (2024-12-01)

Eosinophilia with STAT5BN642H Mutation: A Heterogeneous Entity with Overlapping Morphological Features and Poor Outcome
by: Venkat Chittapragada, et al.
Published: (2024-12-01)

Pathogenesis of Myeloproliferative Neoplasms: Role and Mechanisms of Chronic Inflammation
by: Sylvie Hermouet, et al.
Published: (2015-01-01)

Safety and efficacy of combination therapy of interferon‐α2 and ruxolitinib in polycythemia vera and myelofibrosis
by: Stine Ulrik Mikkelsen, et al.
Published: (2018-08-01)

Exogenous Janus Kinase 617 Codon Influences Small Noncoding RNAs and Gene Expression in Ba/F3 Cells
by: Yi-Yang Chen, et al.
Published: (2024-12-01)

The Hematopoietic Niche in Myeloproliferative Neoplasms
by: Annette H. Schmitt-Graeff, et al.
Published: (2015-01-01)

Promising Findings in Myeloproliferative Neoplasms and AL Amyloidosis
by: Axel Rüfer
Published: (2022-10-01)

Patient‐reported symptom burden and impact on daily activities in chronic graft‐versus‐host disease
by: Jingbo Yu, et al.
Published: (2023-02-01)

Low Renalase Levels in Newly Diagnosed CML: Dysregulation Sensitive to Modulation by Tyrosine Kinase Inhibitors
by: Jelena Milenkovic, et al.
Published: (2024-12-01)

Inflammation as a Driver of Clonal Evolution in Myeloproliferative Neoplasm
by: Angela G. Fleischman
Published: (2015-01-01)

Ph-negative chronic myeloproliferative neoplasm (primary myelofibrosis)– as one of the reasons of the Budd-Chiari syndrome.
by: Maria Dmitrievna Sanatko
Published: (2012-01-01)

Ph-negative chronic myeloproliferative neoplasm (primary myelofibrosis)– as one of the reasons of the Budd-Chiari syndrome.
by: Maria Dmitrievna Sanatko
Published: (2012-06-01)

Pathogenesis and management of high molecular risk myeloproliferative neoplasms
by: Victoria Y. Ling, et al.
Published: (2024-12-01)

Frequency of Calreticulin Genotype among JAK2V617F-negative Patients Suspected with Essential Thrombocythemia
by: Mushtaq M. Khazeem, et al.
Published: (2024-12-01)

Precision Medicine in BCR-ABL1 Negative Myeloproliferative Neoplasms
by: Linet Njue, et al.
Published: (2020-12-01)

Evolution of myeloproliferative neoplasms from normal blood stem cells
by: Sahand Hormoz, et al.
Published: (2024-12-01)